HemaCare Corp. and Charles River Labs have formed a strategic partnership to advance human immune system research by developing a more efficient and reliable method of working with humanized mice.   HemaCare’s peripheral blood mononuclear cells (PBMCs) will be integrated into Charles River’s NCG/PBMC Select Humanization Kit. This kit is the first of its kind and aims to provide both the NCG mouse and vials of pre-selected human PBMCs, allowing researchers to efficiently develop the humanized m...